Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroectodermal Tumors × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 150 Breast Neoplasms 136 Prostatic Neoplasms 121 Lung Neoplasms 119 Glioblastoma 105 Head and Neck Neoplasms 102 Rectal Neoplasms 90 Lymphoma 90 Squamous Cell Carcinoma of Head and Neck 84 Esophageal Neoplasms 82 Pancreatic Neoplasms 65 Leukemia 62 Esophageal Squamous Cell Carcinoma 60 Neoplasms 59 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Lymphoma, Non-Hodgkin 53 Lymphoma, Follicular 53 Brain Neoplasms 52 Hodgkin Disease 50 Lymphoma, Large B-Cell, Diffuse 48 Gliosarcoma 46 Leukemia, Lymphocytic, Chronic, B-Cell 45 Central Nervous System Neoplasms 44 Uterine Cervical Neoplasms 41 Colorectal Neoplasms 41 Sarcoma 40 Lymphoma, Large-Cell, Immunoblastic 39 Glioma 39 Burkitt Lymphoma 38 Lymphoma, Mantle-Cell 37

Interventions

Temozolomide 2 lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 Vincristine 1 Valproic Acid 1 Thiotepa 1 Sunitinib 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Maintenance Chemotherapy 1 Lutetium-177 1 Lutetium 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Cisplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Aminolevulinic Acid 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡